學門類別
哈佛
- General Management
- Marketing
- Entrepreneurship
- International Business
- Accounting
- Finance
- Operations Management
- Strategy
- Human Resource Management
- Social Enterprise
- Business Ethics
- Organizational Behavior
- Information Technology
- Negotiation
- Business & Government Relations
- Service Management
- Sales
- Economics
- Teaching & the Case Method
最新個案
- A practical guide to SEC ï¬nancial reporting and disclosures for successful regulatory crowdfunding
- Quality shareholders versus transient investors: The alarming case of product recalls
- The Health Equity Accelerator at Boston Medical Center
- Monosha Biotech: Growth Challenges of a Social Enterprise Brand
- Assessing the Value of Unifying and De-duplicating Customer Data, Spreadsheet Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise, Data Supplement
- Building an AI First Snack Company: A Hands-on Generative AI Exercise
- Board Director Dilemmas: The Tradeoffs of Board Selection
- Barbie: Reviving a Cultural Icon at Mattel (Abridged)
- Happiness Capital: A Hundred-Year-Old Family Business's Quest to Create Happiness
Pharmeasy: Expansion Dilemma Amidst Regulatory Uncertainties
內容大綱
The two co-founders of PharmEasy, an online medical store and pharmacy website launched in 2015, faced a new challenge in December 2018. Recent judgments by the Madras and Delhi High Courts had suspended the operations of India's more than 250 online pharmacies until new industry regulations could be drafted. Only a few months earlier, in August 2018, the Indian government had released proposed draft regulations for the online sale of medicine. However, an organization representing more than 850,000 pharmacists in India had staged a one-day strike to protest the government's proposal. Should PharmEasy take a cautious approach with its ambitious expansion plans until the government introduces regulations? Or would its competitors seize the opportunity to move forward aggressively to gain market share? The co-founders recognized that the regulatory uncertainty was creating confusion. They needed to decide on their next steps quickly-and communicate their intentions to all stakeholders.